Financials data is unavailable for this security.
Cash flow in JPYView more
In 2024, cash reserves at Stella Pharma Corp fell by 657.49m. Cash Flow from Financing totalled 228.35m or 84.73% of revenues. In addition the company used 876.84m for operations while cash used for investing totalled 9.01m.
Cash flow per share | -21.62 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 90.49 |
---|---|
Tangible book value per share | 88.93 |
More ▼
Balance sheet in JPYView more
Current ratio | 22.82 |
---|---|
Quick ratio | 17.82 |
Total debt/total equity | 0.2771 |
---|---|
Total debt/total capital | 0.217 |
More ▼